|

AR882 75 mg Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Arthrosi Therapeutics1

Indications

  • Tophaceous Gout1
  • Uncontrolled Gout1
  • Refractory Gout1
  • Gout Chronic1
  • Gouty Arthritis1

Margate, Florida1 trial

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

Arthrosi Investigative Site (105)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.